tiprankstipranks
COSCIENS Biopharma (CSCIF)
OTHER OTC:CSCIF
US Market
CSCIF
COSCIENS Biopharma
RESEARCH TOOLSreports
Want to see CSCIF full AI Analyst Report?

COSCIENS Biopharma (CSCIF) Income Statement

906 Followers

COSCIENS Biopharma Income Statement

Last quarter (Q2 2024), COSCIENS Biopharma's total revenue was $2.34M, an increase of 4.05% from the same quarter last year. In Q2, COSCIENS Biopharma's net income was $-1.42M. See COSCIENS Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 4.50M$ 5.64M$ 5.26M$ 3.65M$ 532.00K
Gross Profit
$ 4.28M$ 5.48M$ 5.17M$ 1.33M$ 122.00K
Operating Expenses
$ 22.28M$ 20.74M$ 13.84M$ 7.40M$ 9.67M
Depreciation and Amortization
$ 16.00K$ 16.00K$ 145.00K$ 232.00K$ 315.00K
EBITDA
$ -17.99M$ -15.36M$ 2.85M$ -5.69M$ -9.23M
Operating Income
$ -18.01M$ -15.38M$ -8.67M$ -5.92M$ -9.54M
Other Income/Expenses
$ 1.46M$ -7.35M$ 194.00K$ 1.20M$ 3.48M
Pretax Income
$ -16.55M$ -22.73M$ -8.48M$ -4.72M$ -6.23M
Net Income
$ -3.55M$ 3.24M$ 2.64M$ 1.46M$ -6.04M
Per Share Metrics
Basic EPS
$ -1.92$ 1.87$ 1.33$ 0.66$ -8.75
Diluted EPS
$ -1.92$ 1.87$ 1.33$ 0.66$ -8.63
Weighted Average Shares Outstanding
 4.86M 4.86M 4.60M 1.64M 690.51K
Weighted Average Shares Outstanding (Diluted)
 4.86M 4.86M 4.60M 1.64M 699.78K
Currency in USD

COSCIENS Biopharma Earnings and Revenue History